Metabolism and Target Organ Damage
All Journals
Search Log In
Editor-in-Chief: Amedeo Lonardo
Indexing: ESCI, Scopus, CAS, Dimensions, Lens, CNKI,
Submission to first decision: 58 days
Home Articles Special Issues Volumes Webinars Videos
Metabolism and Target Organ Damage
Search Submit
Editor-in-Chief: Amedeo Lonardo
Submission to first decision: 58 days
Home Articles Special Issues Volumes Webinars Videos

Metabolism and Target Organ Damage

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Impact of sociodemographic factors and baseline health insurance coverage on 1-year outcomes following bariatric surgery

Articles

Most Recent | Most Viewed | Most Downloaded

Intestinal TM6SF2 and the gut-liver axis in MASLD: new insights

Markos Kalligeros, ...Zobair M. Younossi,
Open Access Commentary DOI: 10.20517/mtod.2025.37 16 Jul 2025
Views: Downloads:
Download PDF

Causal relationships among seven cardiovascular-associated metabolic diseases: insights from a bidirectional Mendelian randomization study

Zihao Lai, ...Xiaofei Li,
Open Access Original Article DOI: 10.20517/mtod.2025.20 16 Jul 2025
Views: Downloads:
Download PDF

Bilirubin ameliorates metabolic dysregulation by targeting the HSP90β/SREBPs signaling axis to improve insulin resistance and mitigate ectopic lipid deposition

Jing Zhu, ...Zu-Guo Zheng,
Open Access Original Article DOI: 10.20517/mtod.2025.47 29 Jun 2025
Views: Downloads:
Download PDF

Lipid metabolism in liver transplantation: from challenge to chance

Yuguan Zhang, ...Zhongjun Wu,
Open Access Review DOI: 10.20517/mtod.2025.03 23 Jun 2025
Views: Downloads:
Download PDF

Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes

Josh Bilson, ...Christopher D. Byrne,
Open Access Perspective DOI: 10.20517/mtod.2025.28 28 May 2025
Views: Downloads:
Download PDF

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Stefano BallestriStefano Ballestri, ... Amedeo LonardoAmedeo Lonardo
Open Access Review DOI: 10.20517/mtod.2022.23 30 Jan 2023
Views: Downloads:
Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Christopher D. ByrneChristopher D. Byrne, Giovanni TargherGiovanni Targher
Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024
Views: Downloads:
Download PDF

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Simonetta Lugari, ... Amedeo LonardoAmedeo Lonardo
Open Access Review DOI: 10.20517/mtod.2022.38 30 Mar 2023
Views: Downloads:
Download PDF

Coming soon.

For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
metabolic syndrome
kidney
atherosclerosis
endocrine disorder
NAFLD
diabetes
MAFLD
adipose tissue
obesity
obesity
metabolism
fatty liver
steatosis
fibrosis
cardiovascular
insulin resistance
hypertension
metabolomics
precision medicine
hypertriglyceridemia
Topic: Organ Dysfunction in Metabolic-Associated Fatty Liver Disease: Effect of Cofactors
Topic: Sex Differences in Dysmetabolic Organ Damage and Senescence
Topic: Metabolic and Bariatric Surgery: Current Situation and Future Challenges
Volume 5, Issue 2 (in progress)
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 2
Volume 1, Issue 1
MetALD: Opportunities and Challenges
Replay now available — uncover key perspectives from leading experts.
A Special Interview with Prof. Francesco Giorgino on Emerging Topics in Diabetes Mellitus: From p66Shc to Sex Hormones
Prof. Francesco Giorgino is the Senior Vice President of the European Association for the Study of Diabetes (EASD), Professor of Endocrinology at the University of Bari Aldo Moro, and Chief of the Division of Endocrinology at the University Hospital Policlinico Consorziale in Bari, Italy.
Webinar: The Growing Burden in Challenges in MASLD/MAFLD/NAFLD
This webinar, chaired by internationally renowned expert Prof. Zobair Younossi, will address the key challenges surrounding MASLD/MAFLD/NAFLD and explore its increasing impact on global health.
Call for Papers: Metabolic and Alcohol-Related Dual Liver Injury: Exploring MetALD
This Special Issue aims to explore the dual impact of these factors on liver health, specifically focusing on Metabolic Dysfunction and Alcohol-associated Liver Disease (MetALD).
Congratulations! Twenty-eight Editorial Board Members of Metabolism and Target Organ Damage Named among World’s Top 2% of Scientists for 2024!
This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Impact of sociodemographic factors and baseline health insurance coverage on 1-year outcomes following bariatric surgery

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano BallestriStefano Ballestri, ... Amedeo LonardoAmedeo Lonardo
Open Access | Review | 30 Jan 2023
Views: | Downloads:
Download PDF
MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?
Christopher D. ByrneChristopher D. Byrne, Giovanni TargherGiovanni Targher
Open Access | Perspective | 26 Feb 2024
Views: | Downloads:
Download PDF
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
Simonetta Lugari, ... Amedeo LonardoAmedeo Lonardo
Open Access | Review | 30 Mar 2023
Views: | Downloads:
Download PDF

Coming soon.

Volume 5, Issue 2 (in progress)
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 2
Volume 1, Issue 1
Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties